StonvexLoading…
StonvexStonvexStonvexCore line items from REGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.34B | $14.20B | $13.12B | $12.17B |
Operating Income | $3.58B | $3.99B | $4.05B | $4.74B |
Net Income | $4.50B | $4.41B | $3.95B | $4.34B |
EPS (Diluted) | $41.48 | $38.34 | $34.77 | $38.22 |
Total Assets | $40.56B | $37.76B | $33.08B | $29.21B |
Total Liabilities | $9.30B | $8.41B | $7.11B | $6.55B |
Cash & Equivalents | $3.12B | $2.49B | $2.73B | $3.11B |
Free Cash Flow OCF − CapEx | $4.08B | $3.66B | $3.88B | $4.42B |
Shares Outstanding | 108.60M | 115.10M | 113.70M | 113.50M |